Clinical Trial Update: Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability [Phase 2]

View source ↗

Summary

Phase 2 trial update for levetiracetam in Alzheimer's disease-associated network hyperexcitability completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: University of Minnesota | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-05-16